Novant Health is dedicated to providing the latest treatment options to patients in our community through participation in research.
All clinical trials have one thing in common: the volunteer subject. Without the participation of human volunteers, no new drugs or therapies would be available to treat those suffering from disorder and disease. Indeed, the U.S. drug and device approval system, under the direction of the U.S. Food and Drug Administration (FDA) requires that any new drug or device be thoroughly tested before being made available to the general public. This makes the volunteer subject the most important part of the approval process. For this reason, volunteering for clinical research has been described by some as medical heroism.
Novant Health Clinical Research is governed by, and fully compliant with, regulations emanating from the FDA and other regulatory bodies that assure that risks are minimized and fully disclosed to participants in the informed consent process.
The Novant Health Heart and Vascular Institute is a leader in national and international cardiovascular research. Our dedication to extensive drug and device research ensures the availability of the latest cardiovascular treatments for our patients. We are continually involved in studies of new drugs, interventional procedures, surgical procedures and other medical devices that will benefit our patients. The Presbyterian Cardiovascular Institute has been the top enroller statewide, nationally and internationally for numerous trials.